RxDoctor Payments DataLook up a doctor →

Andrey Seluzhitskiy, MD

Family Medicine · New Carlisle, INNPI 1568452902

Payments from drug & device makers

$36,953in general payments, 2019–2025

Across 1,405 payments — averaging $26.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Verity Pharmaceuticals Inc.$7K
  • Viiv Healthcare Company$4K
  • Amgen$3K
  • AbbVie$3K
  • Novo Nordisk$2K
  • Johnson & Johnson$1K
  • plus $18K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Verity Pharmaceuticals Inc.15$7,011
Viiv Healthcare Company155$3,879
Amgen(2 entities)101$2,652
AbbVie(2 entities)160$2,560
Novo Nordisk116$2,009
Johnson & Johnson(3 entities)65$1,312
Merck81$1,307
Boehringer Ingelheim57$1,092
Pfizer55$991
Shionogi Inc1$975
GSK60$951
Janssen Products, LP8$780
Sunovion Pharmaceuticals Inc.37$677
Napo Pharmaceuticals Inc27$658
Axsome Therapeutics, Inc.22$589
Gilead34$583
Mylan Specialty L.p.23$565
Takeda Pharmaceuticals U.S.A., Inc.31$545
Corium, LLC22$502
Lilly USA, LLC25$460
Paratek Pharmaceuticals, Inc.24$434
AstraZeneca26$424
EMD Serono, Inc.16$342
Abbott11$329
Antares Pharma, Inc.18$328
Amarin Pharma, Inc.16$302
Bayer15$299
Ardelyx, Inc.9$286
Lundbeck LLC15$282
Insulet Corporation5$270
Esperion Therapeutics, Inc.8$254
Astellas Pharma US Inc8$238
Sumitomo Pharma America, Inc.11$235
Kowa Pharmaceuticals America, Inc.18$211
Eisai Inc.7$206
Phathom Pharmaceuticals, Inc.5$196
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)9$193
Otsuka America Pharmaceutical, Inc.7$187
Biohaven Pharmaceuticals, Inc.4$182
Biohaven Pharmaceutical Holding Company Ltd.8$165
Novartis7$157
Sanofi-aventis U.S. LLC7$133
Endo Pharmaceuticals Inc.8$131
Theratechnologies Inc.4$127
Urovant Sciences Inc1$125
Idorsia Pharmaceuticals US Inc6$111
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$100
Exact Sciences5$98
Dexcom, Inc.5$90
Teva Pharmaceuticals USA, Inc.6$76
Halozyme Inc3$56
Assertio Therapeutics, Inc.3$51
Radius Health, Inc.2$38
Supernus Pharmaceuticals, Inc.2$37
Biogen2$36
Genentech USA, Inc.2$33
Nabriva Therapeutics, PLC2$32
Viatris Specialty LLC1$23
Clarus Therapeutics Inc.2$22
Neurocrine Biosciences, Inc.1$17

How this compares

$36,953 in reported general payments places this provider in the 95th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana →

Medicare billing

Part B allowed, 2024
$224,292
Medicare patients
269
Services billed
37,132

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in New Carlisle

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →